Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachel J Perry

Showing results (21-30 of 117) with videos related to

Pageof 12
Sort By:
Advances in Genetics|May 23, 2025
Genetic underpinnnings of type 2 diabetesAditya Shah, Clancy O Bush, Rachel J Perry
Annual Review of Pharmacology and Toxicology|January 10, 2019
Emerging Pharmacological Targets for the Treatment of Nonalcoholic Fatty Liver Disease, Insulin Resistance, and Type 2 DiabetesLeigh Goedeke, Rachel J Perry, Gerald I Shulman
Translational Breast Cancer Research : a Journal Focusing on Translational Research in Breast Cancer|February 21, 2025
Breast cancer shares many epidemiological, lifestyle, and local hormonal and metabolic underpinnings with endometrial and ovarian cancer: a narrative reviewYanitza M Rodríguez, Abigail A Koomson, Rachel J Perry
Physiological Reports|February 18, 2022
An optimized method for tissue glycogen quantificationKyle J Schaubroeck, Brooks P Leitner, Rachel J Perry
Diabetologia|March 11, 2016
Pleotropic effects of leptin to reverse insulin resistance and diabetic ketoacidosisRachel J Perry, Kitt Falk Petersen, Gerald I Shulman
Cell Metabolism|January 8, 2025
The other side of the incretin story: GIPR signaling in energy homeostasisSusana C B R Nakandakari, Andin E Fosam, Rachel J Perry
Plos One|June 13, 2019
Obesity-associated, but not obesity-independent, tumors respond to insulin by increasing mitochondrial glucose oxidationAviva Rabin-Court, Marcos R Rodrigues, Xian-Man Zhang, et al.
Nature|June 6, 2014
The role of hepatic lipids in hepatic insulin resistance and type 2 diabetesRachel J Perry, Varman T Samuel, Kitt F Petersen, et al.
The Biochemical Journal|March 4, 2022
Insulin and cancer: a tangled webBrooks P Leitner, Stephan Siebel, Ngozi D Akingbesote, et al.
Cancer & Metabolism|December 24, 2019
SGLT2 inhibition slows tumor growth in mice by reversing hyperinsulinemiaAli R Nasiri, Marcos R Rodrigues, Zongyu Li, et al.
Pageof 12

Showing results (21-30 of 117) with videos related to

Sort By:
Pageof 12
Advances in Genetics|May 23, 2025
Genetic underpinnnings of type 2 diabetesAditya Shah, Clancy O Bush, Rachel J Perry
Annual Review of Pharmacology and Toxicology|January 10, 2019
Emerging Pharmacological Targets for the Treatment of Nonalcoholic Fatty Liver Disease, Insulin Resistance, and Type 2 DiabetesLeigh Goedeke, Rachel J Perry, Gerald I Shulman
Translational Breast Cancer Research : a Journal Focusing on Translational Research in Breast Cancer|February 21, 2025
Breast cancer shares many epidemiological, lifestyle, and local hormonal and metabolic underpinnings with endometrial and ovarian cancer: a narrative reviewYanitza M Rodríguez, Abigail A Koomson, Rachel J Perry
Physiological Reports|February 18, 2022
An optimized method for tissue glycogen quantificationKyle J Schaubroeck, Brooks P Leitner, Rachel J Perry
Diabetologia|March 11, 2016
Pleotropic effects of leptin to reverse insulin resistance and diabetic ketoacidosisRachel J Perry, Kitt Falk Petersen, Gerald I Shulman
Cell Metabolism|January 8, 2025
The other side of the incretin story: GIPR signaling in energy homeostasisSusana C B R Nakandakari, Andin E Fosam, Rachel J Perry
Plos One|June 13, 2019
Obesity-associated, but not obesity-independent, tumors respond to insulin by increasing mitochondrial glucose oxidationAviva Rabin-Court, Marcos R Rodrigues, Xian-Man Zhang, et al.
Nature|June 6, 2014
The role of hepatic lipids in hepatic insulin resistance and type 2 diabetesRachel J Perry, Varman T Samuel, Kitt F Petersen, et al.
The Biochemical Journal|March 4, 2022
Insulin and cancer: a tangled webBrooks P Leitner, Stephan Siebel, Ngozi D Akingbesote, et al.
Cancer & Metabolism|December 24, 2019
SGLT2 inhibition slows tumor growth in mice by reversing hyperinsulinemiaAli R Nasiri, Marcos R Rodrigues, Zongyu Li, et al.
Pageof 12